EDGEMOND JAMES bought UTHR
May 18, 2026 · Form 4 insider transaction
EDGEMOND JAMES bought 7,500 shares of United Therapeutics Corporation at $117.76 per share, a transaction worth $883.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
$117.76
Total value
$883.2K
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 18, 2026
Filing dateMay 19, 2026
Shares owned after28,876
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.